Optimizing bone health in children and adolescents

NH Golden, SA Abrams, Committee on Nutrition… - …, 2014 - publications.aap.org
The pediatrician plays a major role in helping optimize bone health in children and
adolescents. This clinical report reviews normal bone acquisition in infants, children, and …

New perspectives on osteogenesis imperfecta

A Forlino, WA Cabral, AM Barnes… - Nature Reviews …, 2011 - nature.com
A new paradigm has emerged for osteogenesis imperfecta as a collagen-related disorder.
The more prevalent autosomal dominant forms of osteogenesis imperfecta are caused by …

Bisphosphonate therapy for osteogenesis imperfecta

K Dwan, CA Phillipi, RD Steiner… - Cochrane database of …, 2016 - cochranelibrary.com
Background Osteogenesis imperfecta is caused by a genetic defect resulting in an abnormal
type I collagen bone matrix which typically results in multiple fractures with little or no …

Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases

HZ Ke, WG Richards, X Li, MS Ominsky - Endocrine reviews, 2012 - academic.oup.com
The processes of bone growth, modeling, and remodeling determine the structure, mass,
and biomechanical properties of the skeleton. Dysregulated bone resorption or bone …

Osteogenesis imperfecta

JC Marini, WA Cabral - Genetics of bone biology and skeletal disease, 2018 - Elsevier
Osteogenesis imperfecta is a genetic disorder characterized by low bone mass, decreased
bone strength, increased bone fragility, and shortened stature. Autosomal dominant …

Osteogenesis imperfecta in children and adolescents—new developments in diagnosis and treatment

P Trejo, F Rauch - Osteoporosis International, 2016 - Springer
Osteogenesis imperfecta (OI) is the most prevalent heritable bone fragility disorder in
children. It has been known for three decades that the majority of individuals with OI have …

Osteogenesis imperfecta–a clinical update

S Tournis, AD Dede - Metabolism, 2018 - Elsevier
Osteogenesis imperfecta (OI) is the most common inherited form of bone fragility and
includes a heterogenous group of genetic disorders which most commonly result from …

Osteogenesis imperfecta and therapeutics

R Morello - Matrix Biology, 2018 - Elsevier
Osteogenesis imperfecta, or brittle bone disease, is a congenital disease that primarily
causes low bone mass and bone fractures but it can negatively affect other organs. It is …

The management of osteoporosis in children

LM Ward, VN Konji, J Ma - Osteoporosis International, 2016 - Springer
This article reviews the manifestations and risk factors associated with osteoporosis in
childhood, the definition of osteoporosis and recommendations for monitoring and …

[HTML][HTML] Safety and efficacy of denosumab in children with osteogenesis imperfecta-a first prospective trial

H Hoyer-Kuhn, J Franklin, G Allo, M Kron… - … of musculoskeletal & …, 2016 - ncbi.nlm.nih.gov
Objectives: Osteogenesis imperfecta (OI) is a rare hereditary disease leading to bone
fragility. Denosumab as a RANK ligand antibody inhibiting osteoclast maturation has been …